Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Heijmen

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Brachytherapy|July 10, 2025
Rule-based AI automated adaptive treatment planning for image guided cervical cancer brachytherapyLinda Rossi, Rik Bijman, Supriya Chopra, et al.
The Lancet. Oncology|March 13, 2016
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trialShafak Aluwini, Floris Pos, Erik Schimmel, et al.
The Lancet. Oncology|June 25, 2016
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trialLuca Incrocci, Ruud C Wortel, Wendimagegn Ghidey Alemayehu, et al.
The Lancet. Oncology|February 7, 2015
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trialShafak Aluwini, Floris Pos, Erik Schimmel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2025
Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapyLinda Rossi, Rik Bijman, Henrike Westerveld, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2011
Single vocal cord irradiation: a competitive treatment strategy in early glottic cancerPeter C Levendag, David N Teguh, Fatma Keskin-Cambay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 25, 2020
Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changesJenny Bertholet, Gail Anastasi, David Noble, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2020
The role of computational methods for automating and improving clinical target volume definitionJan Unkelbach, Thomas Bortfeld, Carlos E Cardenas, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 16, 2021
Towards an updated ESTRO-EFOMP core curriculum for education and training of medical physics experts in radiotherapy - A survey of current education and training practice in EuropeCristina Garibaldi, Marion Essers, Ben Heijmen, et al.
Technical Innovations & Patient Support in Radiation Oncology|October 17, 2022
Postgraduate education in radiation oncology during the COVID-19 pandemic - What did we learn?Jesper Grau Eriksen, Luca Boldrini, Eduard Gershkevitsh, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Brachytherapy|July 10, 2025
Rule-based AI automated adaptive treatment planning for image guided cervical cancer brachytherapyLinda Rossi, Rik Bijman, Supriya Chopra, et al.
The Lancet. Oncology|March 13, 2016
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trialShafak Aluwini, Floris Pos, Erik Schimmel, et al.
The Lancet. Oncology|June 25, 2016
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trialLuca Incrocci, Ruud C Wortel, Wendimagegn Ghidey Alemayehu, et al.
The Lancet. Oncology|February 7, 2015
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trialShafak Aluwini, Floris Pos, Erik Schimmel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2025
Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapyLinda Rossi, Rik Bijman, Henrike Westerveld, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2011
Single vocal cord irradiation: a competitive treatment strategy in early glottic cancerPeter C Levendag, David N Teguh, Fatma Keskin-Cambay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 25, 2020
Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changesJenny Bertholet, Gail Anastasi, David Noble, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2020
The role of computational methods for automating and improving clinical target volume definitionJan Unkelbach, Thomas Bortfeld, Carlos E Cardenas, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 16, 2021
Towards an updated ESTRO-EFOMP core curriculum for education and training of medical physics experts in radiotherapy - A survey of current education and training practice in EuropeCristina Garibaldi, Marion Essers, Ben Heijmen, et al.
Technical Innovations & Patient Support in Radiation Oncology|October 17, 2022
Postgraduate education in radiation oncology during the COVID-19 pandemic - What did we learn?Jesper Grau Eriksen, Luca Boldrini, Eduard Gershkevitsh, et al.
Pageof 8